SUMO modification of ion channels

SUMO Regulation of Cellular Processes

Volumn , Issue , 2009, Pages 117-136

  Benson, Mark ^a   Iñiguez Lluhí, Jorge A ^a   Martens, Jeffrey ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Ligand gated channels; Potassium channels; Voltage gated channels

Indexed keywords

EID: 84883187728     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-2649-1_7     Document Type: Chapter

References (49)

1. Amos, G. J., Wettwer, E., Metzger, F., Li, Q., Himmel, H. M. and Ravens, U., 1996, Differences between outward currents of human atrial and subepicardial ventricular myocytes. J. Physiol. 491, 31-50.
2. Benson, M. D., Li, Q. J., Kieckhafer, K., Dudek, D., Whorton, M. R., Sunahara, R. K., Iniguez-Lluhi, J. A. and Martens, J. R., 2007, SUMO modification regulates inactivation of the voltagegated potassium channel Kv1. 5. Proc. Natl. Acad. Sci. U. S. A. 104, 1805-1810.
3. Brendel, J. and Peukert, S., 2003, Blockers of the Kv1. 5 channel for the treatment of atrial arrhythmias. Curr. Med. Chem. Cardiovasc. Hematol. Agents 1, 273-287.
4. Camm, A. J. and Savelieva, I., 2004, Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now? Heart Rhythm 1, 244-246.
5. Collingridge, G. L., Olsen, R. W., Peters, J. and Spedding, M., 2008, A nomenclature for ligandgated ion channels. Neuropharmacology56, 2-5, PMID 18655795.
6. Drolet, B., Simard, C., Mizoue, L. and Roden, D. M., 2005, Human cardiac potassium channel DNA polymorphism modulates access to drug-binding site and causes drug resistance. J. Clin. Invest. 115, 2209-2213.
7. Feliciangeli, S., Bendahhou, S., Sandoz, G., Gounon, P., Reichold, M., Warth, R., Lazdunski, M., Barhanin, J. and Lesage, F., 2007, Does sumoylation control K2P1/TWIK1 background K+ channels? Cell 130, 563-569.
8. Fraser, A. G., Kamath, R. S., Zipperlen, P., Martinez-Campos, M., Sohrmann, M. and Ahringer, J., 2000, Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408, 325-330.
9. Geiss-Friedlander, R. andMelchior, F., 2007, Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956.
10. Gibb, S. L., Boston-Howes, W., Lavina, Z. S., Gustincich, S., Brown, R. H., Jr., Pasinelli, P. and Trotti, D., 2007, A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis. J. Biol. Chem. 282, 32480-32490.
11. Giorgino, F., De Robertis, O., Laviola, L., Montrone, C., Perrini, S., Mccowen, K. C. and Smith, R. J., 2000, The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. Proc. Natl. Acad. Sci. U. S. A. 97, 1125-1130.
12. Gutman, G. A., Chandy, K. G., Grissmer, S., Lazdunski, M., Mckinnon, D., Pardo, L. A., Robertson, G. A., Rudy, B., Sanguinetti, M. C., Stuhmer,W. andWang, X., 2005, International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 57, 473-508.
13. Honore, E., 2007, The neuronal background K2P channels: focus on TREK1. Nat. Rev. Neurosci. 8, 251-261.
14. Iniguez-Lluhi, J. A. and Pearce, D., 2000, A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol. Cell. Biol. 20, 6040-6050.
15. Johnson, E. S., 2004, Protein modification by SUMO. Annu. Rev. Biochem. 73, 355-382.
16. Johnson, E. S. and Blobel, G., 1999, Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J. Cell. Biol. 147, 981-994.
17. Johnson, E. S., Schwienhorst, I., Dohmen, R. J. and Blobel, G., 1997, The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 16, 5509-5519.
18. Lagrutta, A., Wang, J., Fermini, B. and Salata, J. J., 2006, Novel, potent inhibitors of human Kv1. 5 K+ channels and ultrarapidly activating delayed rectifier potassium current. J. Pharmacol. Exp. Ther. 317, 1054-1063.
19. Long, S. B., Campbell, E. B. and Mackinnon, R., 2005, Crystal structure of a mammalian voltagedependent Shaker family K+ channel. Science 309, 897-903.
20. Lotshaw, D. P., 2007, Biophysical, pharmacological, and functional characteristics of cloned and native mammalian two-pore domain K+ channels. Cell Biochem. Biophys. 47, 209-256.
21. Lupoglazoff, J. M., Denjoy, I., Berthet, M., Neyroud, N., Demay, L., Richard, P., Hainque, B., Vaksmann, G., Klug, D., Leenhardt, A., Maillard, G., Coumel, P. and Guicheney, P., 2001, Notched T waves on Holter recordings enhance detection of patients with LQt2 (HERG) mutations. Circulation 103, 1095-1101.
22. Mahajan, R., Delphin, C., Guan, T., Gerace, L. and Melchior, F., 1997, A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107.
23. Martens, J. R., Navarro-Polanco, R., Coppock, E. A., Nishiyama, A., Parshley, L., Grobaski, T. D. and Tamkun, M. M., 2000, Differential targeting of Shaker-like potassium channels to lipid rafts. J. Biol. Chem. 275, 7443-7446.
24. Martin, S. and Henley, J. M., 2004, Activity-dependent endocytic sorting of kainate receptors to recycling or degradation pathways. EMBO J. 23, 4749-4759.
25. Martin, S., Nishimune, A., Mellor, J. R. and Henley, J. M., 2007a, SUMOylation regulates kainatereceptor-mediated synaptic transmission. Nature 447, 321-325.
26. Martin, S.,Wilkinson, K. A., Nishimune, A. and Henley, J. M., 2007b, Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat. Rev. Neurosci. 8, 948-959.
27. Matunis, M. J., Coutavas, E. and Blobel, G., 1996, A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457-1470.
28. McEwen, D. P., Li, Q., Jackson, S., Jenkins, P. M. and Martens, J. R., 2008, Caveolin regulates kv1. 5 trafficking to cholesterol-rich membrane microdomains. Mol. Pharmacol. 73, 678-685.
29. McEwen, D. P., Schumacher, S. M., Li, Q., Benson, M. D., Iniguez-Lluhi, J. A., Van Genderen, K. M. and Martens, J. R., 2007, Rab-GTPase-dependent endocytic recycling of Kv1. 5 in atrial myocytes. J. Biol. Chem. 282, 29612-29620.
30. Nacerddine, K., Lehembre, F., Bhaumik, M., Artus, J., Cohen-Tannoudji, M., Babinet, C., Pandolfi, P. P. and Dejean, A., 2005, The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9, 769-779.
31. Nunez, L., Vaquero, M., Gomez, R., Caballero, R., Mateos-Caceres, P., Macaya, C., Iriepa, I., Galvez, E., Lopez-Farre, A., Tamargo, J. and Delpon, E., 2006, Nitric oxide blocks hKv1. 5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc. Res. 72, 80-89.
32. Pecini, R., Elming, H., Pedersen, O. D. and Torp-Pedersen, C., 2005, New antiarrhythmic agents for atrial fibrillation and atrial flutter. Expert Opin. Emerg. Drugs 10, 311-322.
33. Pourrier, M., Schram, G. and Nattel, S., 2003, Properties, expression and potential roles of cardiac K+ channel accessory subunits: MinK, MiRPs, KChIP, and KChAP. J. Membr. Biol. 194, 141-152.
34. Rajan, S., Plant, L. D., Rabin,M. L., Butler, M. H. and Goldstein, S. A., 2005, Sumoylation silences the plasma membrane leak K+ channel K2P1. Cell 121, 37-47.
35. Regan, C. P., Wallace, A. A., Cresswell, H. K., Atkins, C. L. and Lynch, J. J., Jr., 2006, In vivo cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker, (2-Isopropyl-5-methylcyclohexyl) diphenylphosphine oxide, in rat and nonhuman primate. J. Pharmacol. Exp. Ther. 316, 727-732.
36. Saitoh, H. and Hinchey, J., 2000, Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252-6258.
37. Saracco, S. A., Miller,M. J., Kurepa, J. and Vierstra, R. D., 2007, Genetic analysis of SUMOylation in Arabidopsis: conjugation of SUMO1 and SUMO2 to nuclear proteins is essential. Plant Physiol. 145, 119-134.
38. Schmidt, J. W. and Catterall, W. A., 1987, Palmitylation, sulfation, and glycosylation of the alpha subunit of the sodium channel. Role of post-translational modifications in channel assembly. J. Biol. Chem. 262, 13713-13723.
39. Schulz, D. J., Temporal, S., Barry, D. M. and Garcia, M. L., 2008, Mechanisms of voltage-gated ion channel regulation: from gene expression to localization. Cell Mol. Life Sci. 65, 2215-2231.
40. Seeler, J. S. and Dejean, A., 2003, Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4, 690-699.
41. Simard, C., Drolet, B., Yang, P., Kim, R. B. and Roden, D. M., 2005, Polymorphism screening in the cardiac K+ channel gene KCNA5. Clin. Pharmacol. Ther. 77, 138-144.
42. Snyders, D. J., 1999, Structure and function of cardiac potassium channels. Cardiovasc. Res. 42, 377-390.
43. Stump, G. L., Wallace, A. A., Regan, C. P. and Lynch, J. J., Jr., 2005, In vivo antiarrhythmic and cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide. J. Pharmacol. Exp. Ther. 315, 1362-1367.
44. Su, H. L. and Li, S. S., 2002, Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. Gene 296, 65-73.
45. Swope, S. L., Moss, S. J., Raymond, L. A. and Huganir, R. L., 1999, Regulation of ligand-gated ion channels by protein phosphorylation. Adv. Second Messenger Phosphoprotein Res. 33, 49-78.
46. Tang, Z., El Far, O., Betz, H. and Scheschonka, A., 2005, Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. J. Biol. Chem. 280, 38153-38159.
47. Wang, Z., Fermini, B. and Nattel, S., 1993, Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1. 5 cloned channel currents. Circ. Res. 73, 1061-1076.
48. Wilkinson, K. A., Nishimune, A. and Henley, J. M., 2008, Analysis of SUMO-1 modification of neuronal proteins containing consensus SUMOylation motifs. Neurosci. Lett. 436, 239-244.
49. Zhang, L., Foster, K., Li, Q. and Martens, J. R., 2007, S-acylation regulates Kv1. 5 channel surface expression. Am. J. Physiol. Cell Physiol. 293, C152-C161.